Neuberger Berman High Yield - NHS EV/EBITDA Multiple

Neuberger Berman (NHS) invests in key transport and infrastructure assets to drive margin growth. The market price visualization on GURU.Markets shows that the indicator is 0.00. A stable cash flow is generated through micro-commissions from massive volumes of assets under management. Meanwhile, financial stability relies on bond coupon income, which necessitates strict oversight of issuer default probabilities.

NHS Neuberger Berman Fund: Total Company Value to Operating Income Before Depreciation Ratio in the range 11/23/2025 - 10/17/2026

NHS (nb.com): analytical breakdowns and indicator data

- market price and analyst price targets:

Price Chart Neuberger Berman Fund|NHS - Broker Consensus Forecast

- issuer market value details:

Market Capitalization Neuberger Berman Group|NHS - Business Value

- issuer book value statistics:

Net Assets per Single Share Neuberger Berman|NHS - Book Valuation of Business|Market Value to Book Value Ratio nb.com|NHS - Total Business Assets

- company total debt and liquidity indicators:

- business earnings and investment ratios data:

NHS - Final Profit|Projected Future Earnings Neuberger Berman|NHS - Market Cap to Net Income Ratio|Forward P/E Multiple Neuberger Berman|NHS - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Neuberger Berman Group|NHS - Income before deduction of interest, taxes and amortization|Net earnings per share for the last 12 months Neuberger Berman|NHS - Earnings per share for the trailing year|Quarterly EPS earnings growth nb.com|NHS - Earnings per share growth in current year|Earnings growth forecast for next year Neuberger Berman

Fundamental company analysis:Neuberger Berman Fund NHS

Product sample of Neuberger Berman High Yield

The EV/EBITDA ratio determines the enterprise value including net debt relative to operating profit, allowing for an assessment of the asset's real value without the influence of tax policy. For Neuberger Berman (NHS), this metric is critical, as the fund's income is based on the management of a debt instrument portfolio and coupon payments. By analyzing the EV/EBITDA dynamics of a capital-intensive business, an investor can see the efficiency of leverage control. The stability of this indicator confirms the resilience of the financial model and minimizes the risk of deep drawdowns.

Who Neuberger Berman competes with

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization FS Credit FSCO|PTA: Enterprise Value to Operating Income Before Depreciation|Brookfield Real Assets - EV/EBITDA Multiple|PAXS (PIMCO Access Income Fund) - Enterprise Value to Operating Income Before Depreciation|Nuveen Variable Rate Preferred & Income Fund (NPFD) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|HFRO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ARDC Fund|Enterprise Value to Operating Income Before Depreciation EIC (Eagle Point Income Corp)|EV/EBITDA Multiple BRW|JGH - Company Value to EBITDA|Nuveen Core Plus Impact - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Western Asset High Yield Defined Opportunity Fund Inc. HYI|Franklin Limited Trust - EV/EBITDA Multiple|OPP: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|HNW: EV/EBITDA Multiple|Company Value to EBITDA Western Asset Global High Income Fund (GDO)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Principal Real Estate Income Fund|JMM: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple CBH|cutwater.com (INSI) - Enterprise Value to EBITDA Multiple|EV/EBITDA Multiple IHTA (Invesco High Income 2024)